August 12, 2019
- Heritage Completes Acquisition of 30% Ownership In Endocanan Health Inc.
- Planet 13 Announces New Edible Brands: HaHa Gummiestm and Dreamland Chocolatestm.
- Vivo Commences Extraction Operations iN Napanee, Ontario.
- Bhang Brings Hemp-derived CBD Product Portfolio to Spain, France, Italy, Belgium, Luxembourg & the U.K.
- Avicanna Announces JV With Sigma Analytical Services Inc.
Heritage Cannabis Holdings Corp. (“Heritage”) (CSE: CANN), part of CGOC’s public portfolio, is focused on becoming a vertically integrated cannabis provider that currently has two Health Canada approved licensed producers, through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp.
July 29, 2019 – Heritage announced that further to its press release dated May 15, 2019, the Company has completed its transaction to acquire 30% of Endocanna Health Inc. (“Endocanna”), Endocanna is a company based in LA, California, that has developed Endocannabinoid DNA testing to assist individuals in taking control of their own health by utilizing cannabis products specifically suited for themselves.
Planet 13 Holdings Inc. (“Planet 13”) (CSE: PLTH), part of CGOC’s public portfolio, is a leading vertically-integrated Nevada based cannabis company.
July 29, 2019 – Planet 13 announced the addition of HaHa GummiesTM and Deamland ChocolatesTM to its growing in-house brand portfolio. HaHa Gummies and Dreamland Chocolates along with Medizin, TRENDI and Leaf & Vine will be produced in Planet 13’s new 15,000 sq. ft. customer-facing production facility located at the Planet 13 Las Vegas Cannabis Entertainment Complex.
Vivo Cannabis Inc. (“Vivo”) (TSX-V: VIVO), part of CGOC’s public portfolio, is a Napanee, Ontario based firm recognized for trusted, premium cannabis products and services.
July 30, 2019 – Vivo announced that its wholly-owned subsidiary, ABcann Medicinals Inc., has received approval from Health Canada to commence extraction operations using its on-site-super-critical CO2 extraction system. Upon receipt of EU-GMP certification for its Napanee facility, the Company is expected to be able to ship extracted cannabis products to Europe and other countries for scientific and medical purposes, subject to receipt of all necessary import and export permits, in addition to selling domestically.
Bhang Inc. (“Bhang”) (CSE: BHNG), part of CGOC’s public portfolio, is a global cannabis house of brands with an extensive, award-winning portfolio of products.
August 6, 2019 – Bhang announced that it has signed an agreement to import and distribute Bhang’s full suite of hemp-derived cannabidiol (CBD) products in key markets across Europe, with distribution into Spain, France, Italy, Belgium, Luxembourg and the U.K. There are currently more than 15 million users of cannabis-derived products in these six European nations, according to a 2019 European Cannabis research report from Prohibition Partners Intelligence and by 2028, these countries will account for more than US$67 billion in cannabis and hemp-derived product sales.
Avicanna Inc. (“Avicanna”) (TSX: AVCN), part of CGOC’s public portfolio, is a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products.
August 8, 2019 – Avicanna announced that it has entered into an agreement with Sigma Analytical Services Inc. to establish a joint venture for the testing of cannabis and cannabis-based products in Colombia. The laboratory will provide a comprehensive suite of cannabis specific testing, which will include pesticides, heavy metals, residual solvents, aflatoxins, microbial, genotyping, and cannabinoid and terpene profiling
|E-UPDATES – Sign up here to be included in our email blasts and receive timely updates
For further information please contact Cannabis Growth Opportunity Corporation: